COMMUNIQUÉS West-GlobeNewswire
-
aTyr Pharma Announces Fourth Quarter and Full Year 2023 Results and Provides Corporate Update
14/03/2024 - 21:00 -
Eton Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results
14/03/2024 - 21:01 -
Vaxart Provides Business Update and Reports Full Year 2023 Financial Results
14/03/2024 - 21:01 -
Allakos Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
14/03/2024 - 21:02 -
Sensus Healthcare to Participate in the 36th Annual Roth Conference
14/03/2024 - 21:05 -
Allogene Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Update
14/03/2024 - 21:05 -
Larimar Therapeutics Reports Fourth Quarter and Full Year 2023 Operating and Financial Results and Provides Update on Nomlabofusp Development
14/03/2024 - 21:05 -
Enliven Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Business Update
14/03/2024 - 21:05 -
Terns Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Updates
14/03/2024 - 21:05 -
Cognition Therapeutics Announces Closing of $11.5 Million Public Offering of Common Stock
14/03/2024 - 21:05 -
Evoke Pharma Reports Fourth Quarter and Full Year 2023 Financial Results
14/03/2024 - 21:05 -
TerrAscend Reports Fourth Quarter and Full Year 2023 Financial Results
14/03/2024 - 21:10 -
Un premier extrait de cannabis médical approuvé au Portugal pour Tilray Medical
14/03/2024 - 21:10 -
HeartSciences Reports Third Quarter Fiscal 2024 Financial Results
14/03/2024 - 21:15 -
Madrigal Pharmaceuticals Announces FDA Approval of Rezdiffra™ (resmetirom) for the Treatment of Patients with Noncirrhotic Nonalcoholic Steatohepatitis (NASH) with Moderate to Advanced Liver Fibrosis
14/03/2024 - 21:15 -
Taysha Gene Therapies to Release Full-Year 2023 Financial Results, Provide Corporate and Clinical Updates and Host Conference Call on March 19
14/03/2024 - 21:26 -
IntelGenx to Report Fourth Quarter and Full Year 2023 Financial Results on March 21, 2024 – Conference Call to Follow
14/03/2024 - 21:30 -
Intuitive Announces FDA Clearance of Fifth-Generation Robotic System, da Vinci 5
14/03/2024 - 21:30 -
Dyadic to Report Full Year 2023 Financial Results and Host Conference call on Thursday, March 28, 2024
14/03/2024 - 21:30
Pages